Results 11 to 20 of about 54,453 (265)

Relationship Between Ankylosing Spondylitis and Cerebrovascular Disorders: A Systematic Review [PDF]

Eurasian Journal of Medicine
Cerebrovascular events are linked to ankylosing spondylitis. Accelerated atherosclerosis and endothelial dysfunction against a backdrop of inflammation have been widely blamed for the increased cerebrovascular risk in ankylosing spondylitis.
Mohammad Mahdi Heidari, Azad Khaledi, Amir Mohammad Taravati, Ali Rastegar-Kashkouli, Farzaneh Moammer, Iman Saffar   +5 more
doaj   +2 more sources

Biomarkers of response to therapy in Ankylosing Spondylitis [PDF]

, 2013
Ankylosing Spondylitis (AS) is a chronic inflammatory disorder of the spine which leads to progressive spinal fusion and deformity. With improvements in MRI, this condition is now being recognized earlier.
Pathan, Ejaz Mohammed Ishaq
core   +1 more source

The effect of three years of TNF alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study [PDF]

, 2012
INTRODUCTION: The aim of this study was to investigate the effect of three years of tumor necrosis factor-alpha (TNF-alpha) blocking therapy on bone turnover as well as to analyze the predictive value of early changes in bone turnover markers (BTM) for ...
Eveline van der Veer, Anneke Spoorenberg, Arends, S., Houtman, P.M., Cees G.M. Kallenberg, Leijsma, M.K., Brouwer, E., Reinhard Bos, Elisabeth Brouwer, Kallenberg, C.G., Martha K. Leijsma, Groen, H., Groen, H.; id_orcid, van der Veer, E., Bos, R., Spoorenberg, A., Henk Groen, Suzanne Arends, Pieternella M. Houtman   +18 more
core   +1 more source

Persistent clinical efficacy and safety of anti-tumour necrosis factor \textgreeka therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response [PDF]

, 2008
Background: There is insufficient evidence for the long-term efficacy and safety of anti-tumour necrosis factor therapy in patients with ankylosing spondylitis (AS).
Baraliakos, X., Sieper, J., Zeidler, H., Braun, J., Listing, J., Schewe, Stefan, Burmester, G., Sörensen, H., Krause, A., Schneider, M., Fritz, C., Alten, R.   +11 more
core   +1 more source

ASAS/EULAR recommendations for the management of ankylosing spondylitis [PDF]

, 2006
Objective: To develop evidence based recommendations for the management of ankylosing spondylitis (AS) as a combined effort of the `ASsessment in AS' international working group and the European League Against Rheumatism.Methods: Each of the 22 ...
Sieper, J., Sturrock, R.D., Böhm, H., van Royen, B. J., Pavelka, K, Inman, R.D., Burgos-Vargas, R., Géher, P., Collantes, E, Braun, J., Kvien, TK, Davis Jr., J. C., Kvien, T.K., Leirisalo-Repo, M., Stucki, G., Khan, M.A., Geher, P, Davis, JC, Dijkmans, B., Pavelka, K., Sturrock, RD, Davis, J. C., Stucki, G, van der Heijde, D., Kvien, T. K., Zochling, J., Olivieri, I., Dougados, M, Leirisalo-Repro, M, Wendling, D., Dougados, M., Inman, R. D., Burgos-Vargas, R, Sieper, J, Collantes, E., Dijkmans, B, Olivieri, I, Bohm, H, Zo, Khan, MA, van der, LS, van Royen, BJ, Renseigné, Non, van der, HD, Khan, M. A., Wendling, D, Inman, RD, van der Linden, S., Braun, J, Zo,, Géher, R. D. and Khan, Sturrock, R. D.   +51 more
core   +1 more source

Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis

Genome Biology, 2017
Background The assessment and characterization of the gut microbiome has become a focus of research in the area of human autoimmune diseases. Ankylosing spondylitis is an inflammatory autoimmune disease and evidence showed that ankylosing spondylitis may
Chengping Wen, Zhijun Zheng, Tiejuan Shao, Lin Liu, Zhijun Xie, Emmanuelle Le Chatelier, Zhixing He, Wendi Zhong, Yongsheng Fan, Linshuang Zhang, Haichang Li, Chunyan Wu, Changfeng Hu, Qian Xu, Jia Zhou, Shunfeng Cai, Dawei Wang, Yun Huang, Maxime Breban, Nan Qin, Stanislav Dusko Ehrlich   +20 more
doaj   +1 more source

Summary data ankylosing spondylitis GWAS [PDF]

Summary of association tests for Nature Genetics publication "Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci"
International Genetics of Ankylosing Spondylitis Consortium (IGAS)
core   +3 more sources

ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health [PDF]

, 2010
Objective: To report on the results of a standardised consensus process agreeing on concepts typical and/or relevant when classifying functioning and health in patients with ankylosing spondylitis (AS) based on the International Classification of ...
Stucki, Gerold, van der Horst Bruinsma, I. E., Kostanjsek, Nenad, Maksymowych, W.P., Maksymowych, W., Boonen, A., Braun, J., Bruinsma, I.E.V., Huang, F., Cieza, A., van der Horst Bruinsma, I.E., van der Heijde, D., Bruinsma, I. E. van der Horst, Heijde, D. van der, Cieza, Alarcos, Kostanjsek, N., Huang, Fan, Stucki, G.   +17 more
core   +1 more source

Ankylosing spondylitis and sarcoidosis — Coincidence or association? [PDF]

, 1992
We report a 25-year-old woman presenting with sarcoidosis and bilateral sacroiliitis. Her sarcoidosis related symptoms (malaise, cough and dyspnoea) improved dramatically under treatment with steroids but severe back pain persisted.
Stucki, Gerold, Speich, R., Michel, B. A., Felten, A. von   +3 more
core   +1 more source

Elevated serum interleukin-23 levels in ankylosing spondylitis patients and the relationship with disease activity [PDF]

, 2015
2015-11This study was aimed to evaluate the relationship between serum interleukin-23 (IL-23) levels and ankylosing spondylitis (AS).Twenty male patients diagnosed with ankylosing spondylitis according to the 1984 modified New York criteria for AS and ...
Baygutalp, Nurcan Kilic, Seferoglu, Buminhan, Ugur, Mahir, Baygutalp, Fatih, Altas, Elif Umay, Melikoglu, Meltem Alkan   +5 more
core   +1 more source